Regard turns existing medical records into reviewable clinical intelligence

Regard builds clinical intelligence from information already in a health system’s medical records. It uses that chart context to surface supported findings, draft notes and assist related revenue and population workflows. This makes it different from an ambient scribe that begins with a conversation: Regard’s starting point is the record, and its central promise is making more of that record usable to a reviewer.

01 / ProductOne chart-intelligence layer serves several different teams

The current Regard platform connects Clinical Notes, Mid-Revenue Cycle, HCC Capture and Screening. The company presents a shared diagnostic-intelligence layer underneath these workflows. They should be evaluated separately even when they use the same source material: drafting a note, preparing an appeal and identifying a patient for follow-up have different users, consequences and acceptance criteria.

Clinical Notes combines chart-derived findings with documentation and a conversational agent called Max for querying the record or refining a note. Regard describes support from admission through discharge, with output customized to organizational and clinician needs. The important review task is understanding which source supports a suggested finding and which parts of the note still require the clinician’s judgment.

The technology description separates ingestion, terminology normalization, diagnostic reasoning and clinical governance. Regard says clinicians author and approve diagnostic logic, with version history available for audit. This is a more specific mechanism to investigate than a generic claim that an AI reads charts. It gives a buyer concrete questions about source coverage, local terminology and the version of the logic that produced a finding.

02 / AudienceA fit where existing records contain overlooked context

Regard is relevant when the organization’s problem is extracting usable information from a large record, rather than simply documenting what was said in the latest visit. A hospital team may need help bringing evidence forward for a clinical note; a documentation team may need the same evidence for a later administrative review. The shared input does not remove the need to define who is responsible for each output.

Abridge provides a useful comparison for conversation-led documentation and broader clinical context. Ambience Healthcare offers another platform perspective on documentation and related workflows. Regard’s chart-first approach can be complementary to ambient capture: one starts with existing information, while the other adds the encounter. The buyer should examine where these sources meet and how conflicting or older information is handled.

The offer is less directly suited to a clinician who wants an isolated self-service note tool without an organizational data connection. Regard’s public route is a health-system demonstration. Its value depends on the available record and the quality of local mappings, so a generic demo with ideal data cannot establish how it will behave in a different hospital’s environment.

03 / WorkflowA proposed evaluation starts with the evidence chain

Consider a proposed implementation review using authorized, de-identified or synthetic cases representing the intended service. Select cases with both structured data and narrative records, including an important change over time. Have clinicians identify the relevant source passages before assessing the software. This avoids using the AI’s own output as the only definition of what the chart contains.

First inspect ingestion and mapping. If a local laboratory label or imported document is not recognized correctly, the later assessment can be incomplete even when the reasoning logic works as described. Ask the implementation team to show the source-to-concept mapping for a small set of representative records. Record unavailable data separately from data the system received but interpreted incorrectly.

Next, review a proposed finding and follow its evidence links. Check the date, patient context and relationship between the cited material and the statement. A link is useful only when it supports the actual conclusion. Include a case where an older note conflicts with a later correction, so the reviewer can observe how the system handles chronology rather than merely recognizing a term.

Move the accepted material into the Clinical Notes workflow. Confirm that the clinician can revise or reject a suggestion and that the final note reflects the approved result. If Max is used to edit the note, compare the revised version with the original evidence. A conversational editing interface can make work easier, but it should not obscure which statements have changed or introduce unsupported content during rewriting.

Evaluate downstream outputs independently. For a revenue or HCC exercise, involve the relevant documentation and coding reviewers. For Screening, examine the worklist and the process for acting on it. Measure whether the appropriate person receives enough evidence to decide, and what happens to rejected or unresolved items. These are proposed evaluation steps, not reported results from a Regard deployment.

04 / PricingThe public commercial route is an organization-specific engagement

The demonstration page directs buyers to a health-system conversation rather than a public seat-based checkout. No numerical price, contract minimum or universal deployment fee was established from the reviewed pages. A useful proposal should identify the workflows included, the connected environments and the responsibilities of Regard and the health system.

Do not use a public revenue example as a substitute for a quote or a forecast. The Mid-Revenue Cycle page publishes customer outcomes, but those depend on the organization, case mix, adoption and administrative processes. A local pilot should establish its own starting point and distinguish identified opportunity, accepted documentation and realized financial results. These are different stages of evidence.

The HCC page offers a free gap-analysis route. Confirm its scope, data requirements and output before treating it as a product trial. An opportunity assessment can reveal where to investigate without establishing that every suggested condition is appropriate or that a particular financial result will follow. The organization still needs reviewers and a defined decision process.

05 / DistinctionsChart reasoning and downstream evidence are the key distinctions

Regard’s architecture emphasizes normalizing local clinical language before applying diagnostic logic. That is relevant because the same concept may be represented differently across systems and documents. The practical benefit to inspect is consistency: whether a finding remains traceable when the source uses a local label or a narrative description rather than a standard code.

Mid-Revenue Cycle applies the clinical picture to work such as utilization review, discharge planning and appeal preparation. The point is to make supporting information available earlier and in a usable format. The buyer should look for evidence that the same source remains visible to the downstream reviewer, rather than assuming that a polished generated letter is sufficient support on its own.

HCC Capture describes surfacing both previously documented and new suspected conditions with evidence for risk-adjustment review. This is broader than simply searching for an existing code. It also makes the distinction between a system suggestion and an accepted clinical record more important. A useful implementation exposes that transition and lets the responsible reviewer dismiss a suggestion without losing the audit history.

06 / QuestionsScreening includes both current capabilities and future directions

The Screening page describes evidence-linked worklists and explicitly labels some use cases as future. Its displayed examples include future mitral-regurgitation and reduced-ejection-fraction workflows and future hospital-acquired-condition or patient-safety-indicator screening. A buyer should verify the requested use case directly rather than interpreting the whole page as an available catalog.

Regard makes broad statements about reading the full available chart and about the completeness of its assessments. Treat those as vendor descriptions to test against the configured integration. The meaningful boundary is what information the system actually receives, when it was updated and what happens if a source is unavailable. A claim about coverage cannot establish that every record in a particular health system is connected.

The public technology page provides useful detail about clinician-authored logic and versioning, but it does not replace a local clinical-governance assessment. Ask how a change in diagnostic logic is communicated, how prior results can be reconstructed and how the organization handles disagreement. A reviewer should be able to distinguish a new source fact from a new version of the rule that interprets it.

Finally, align metrics with the job. More accepted suggestions, fewer queries and higher reported revenue are not interchangeable evidence of clinical benefit. Keep documentation quality, review effort, workflow completion and any financial outcomes separate. This allows the organization to learn from a deployment without letting one favorable number obscure a problem elsewhere.

07 / DecisionBuy the reviewable workflow, not the chart-reading headline

Regard deserves consideration when existing clinical records contain information that teams struggle to bring into their work. Its value should be demonstrated through the chain from source data to reviewed finding to completed task. Begin with the workflow whose reviewers can inspect that chain, then expand only when the same clarity survives in other settings.